Preclinical metabolism and disposition of luseogliflozin, a novel antihyperglycemic agent.
about
Evaluation of potential activity of luseogliflozin on vascular proliferation in the mesenteric lymph node with or without vascular tumors in Sprague-Dawley rats in a carcinogenicity study.Sodium glucose co-transporter 2 inhibitor luseogliflozin in the management of type 2 diabetes: a drug safety evaluation.A simple and rapid LC-MS/MS method for quantitation of luseogliflozin in rat plasma and its application to a PK study.Metabolite profiling and enzyme reaction phenotyping of luseogliflozin, a sodium-glucose cotransporter 2 inhibitor, in humans.In vitro evaluation of potential drug interactions mediated by cytochrome P450 and transporters for luseogliflozin, an SGLT2 inhibitor.
P2860
Preclinical metabolism and disposition of luseogliflozin, a novel antihyperglycemic agent.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Preclinical metabolism and dis ...... novel antihyperglycemic agent.
@en
Preclinical metabolism and dis ...... novel antihyperglycemic agent.
@nl
type
label
Preclinical metabolism and dis ...... novel antihyperglycemic agent.
@en
Preclinical metabolism and dis ...... novel antihyperglycemic agent.
@nl
prefLabel
Preclinical metabolism and dis ...... novel antihyperglycemic agent.
@en
Preclinical metabolism and dis ...... novel antihyperglycemic agent.
@nl
P2093
P2860
P1433
P1476
Preclinical metabolism and dis ...... novel antihyperglycemic agent.
@en
P2093
Jun-ichi Yamaguchi
Kenji Hachiuma
Masahiro Ishida
Masatoshi Hasegawa
Nobuko Horiuchi
Yasuhiro Nakai
Yoshiki Fukasawa
Yukihiro Chino
P2860
P304
P356
10.3109/00498254.2015.1042947
P407
P577
2015-07-06T00:00:00Z